Explore the high-impact peer-reviewed research papers generated from our research programme
From our research over the last ten years:
78 research papers have been generated.
Overall, from these 78 research papers there have been more than 2,800 citations in other research/policy work.
68% (53) are open access, meaning unlike the traditional scholarly subscription mode, there is no financial, legal of technical barriers to accessing the publication, hence they can be read by anyone.
ROS funded research has informed UK clinical guidelines for the prevention and treatment of osteoporosis. In 2025, the National Osteoporosis Guideline Group (NOGG) published the updated version of the UK guideline for the assessment and management of osteoporosis and the prevention of fragility fractures in postmenopausal women, and men age 50 years and older (available here). This guideline is relevant for all healthcare professionals involved in osteoporosis management and is accredited by the National Institute of Health and Care Excellence (NICE), the main body in the NHS that manages health guidelines and quality standards. The guideline has been endorsed by the International Osteoporosis Foundation and by the European Society for the Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases. The guideline references seven ROS research grant related papers.
Generating new osteoporosis knowledge
Please see the list below of all the publications over the last 10 years, generated from our investment in research via our Research and Innovation Grants Programme and Research Support Request process. The papers have been catergorised under the different research areas. Titles associated with studies not directly funded by ROS research grants are shown in pink.
Effectiveness of assessment and treatment
Sturrock A, Grabrovaz M, Bullock L, Clark E, Finch T, Haining S, Helliwell T, Horne R, Hyde R, Maidment I, Pryor C, Statham L, Paskins Z. (2024). A person-centred primary care pharmacist-led osteoporosis review for optimising medicines (PHORM): a protocol for the development and co-design of a model consultation intervention. BMJ Open. Nov 2;14(11):e085323 (full paper available here).
Naylor KC, Tenis On E, Hardcastle SA, Lyell V, Gregson CL, Henderson EJ. (2025). Assessing and managing bone health and fracture risk in Parkinson's disease: the BONE PARK 2 protocol. Age Ageing. Mar 3;54(3):afaf052 (full paper available here).
Barker KL, Toye F, Drew S, Khalid TY, Clark EM. (2024). Applicability of Vfrac in men: a qualitative study of an osteoporotic vertebral fracture screening tool for use in older people with back pain. Arch Osteoporos. Nov 19;19(1):117 (full paper available here).
Toye F, Barker KL, Drew S, Khalid TY, Clark EM. (2025). A reflexive thematic analysis of existential losses in men with osteoporosis: "I'm not the person I was somehow … although I am". BMC Musculoskelet Disord. Mar 25;26(1):294 (full paper available here).
Patel R, Bhimjiyani A, Ben-Shlomo Y, Gregson CL. (2021). Social deprivation predicts adverse health outcomes after hospital admission with hip fracture in England. Osteoporos Int. 32(6):1129-1141 (full paper available here).
Bhimjiyani A, Neuburger J, Jones T, Ben-Shlomo Y, Gregson CL. (2017). The effect of social deprivation on hip fracture incidence in England has not changed over 14 years: An analysis of the English Hospital Episodes Statistics (2001-2015). Osteoporos Int. 29(1): 115-124 (full paper available here).
Bhimjiyani A, Neuburger J, Jones T, Ben-Shlomo Y, Gregson CL. (2018). Inequalities in hip fracture incidence are greatest in the North of England: regional analysis of the effects of social deprivation on hip fracture incidence across England. Public health. 162, 25-31 (full paper available here).
Glynn, J, Hollingworth, W, Bhimjiyani A, Ben-Shlomo, Gregson CL. (2020). How does deprivation influence secondary care costs after hip fracture? Osteoporos Int. 31: 1573–1585 (full paper available here).
Henderson EJ, Lyell V, Bhimjiyani A, Amin J, Kobylecki C, Gregson CL. (2019). Management of fracture risk in Parkinson's: A revised algorithm and focused review of treatments. Parkinsonism Relat Disord. 64:181-187 (full paper available here).
Sheehan KJ, Fitzgerald L, Hatherley S, Potter C, Ayis S, Martin FC, Gregson CL, Cameron ID, Beaupre LA, Wyatt D, Milton-Cole R, DiGiorgio S, Sackley C. (2019). Inequity in rehabilitation interventions after hip fracture: a systematic review. Age Ageing. 48(4):489-497 (full paper available here).
Valentin G, Pedersen SE, Christensen R, Friis K, Nielsen CP, Bhimjiyani A, Gregson CL, Langdahl BL. (2020). Socio-economic inequalities in fragility fracture outcomes: a systematic review and meta-analysis of prognostic observational studies. Osteoporos Int. 31(1): 31-42 (full paper available here).
Valentin G, Ravn MB, Jensen EK, Friis K, Bhimjiyani A, Ben-Shlomo Y, Hartley A, Nielsen CP, Langdahl B, Gregson CL. (2021). Socio-economic inequalities in fragility fracture incidence: a systematic review and meta-analysis of 61 observational studies. Osteoporos Int. 32(12):2433-2448 (full paper available here).
Gibson-Smith D, Klop C, Elders PJ, Welsing PM, van Schoor N, Leufkens HG, Harvey NC, van Staa TP, de Vries F. (2014). The risk of major and any (non-hip) fragility fracture after hip fracture in the United Kingdom: 2000-2010. Osteoporos Int. Nov; 25(11):2555-63 (full paper available here).
Curtis EM, Harvey NC, D'Angelo S, Cooper CS, Ward KA, Taylor P, Pearson G, Cooper C. (2016). Bone mineral content and areal density, but not bone area, predict an incident fracture risk: a comparative study in a UK prospective cohort. Archives of Osteoporosis. 11: 1, 39 (full paper available here).
Curtis EM, Moon RJ, Dennison EM, Harvey NC, Cooper C. (2015). Recent advances in the pathogenesis and treatment of osteoporosis. Clinical Medicine (London, England). 16: 4, 360-4 (full paper available here).
Curtis EM, van der Velde R, Moon RJ, van den Bergh JP, Geusens P, de Vries F, van Staa TP, Cooper C, Harvey NC. (2016). Epidemiology of fractures in the United Kingdom 1988-2012: Variation with age, sex, geography, ethnicity and socioeconomic status. Bone. 87:19-26 (full paper available here).
Harvey NC, Curtis EM, van der Velde R, Moon RJ, van den Bergh JP, Geusens P, de Vries F, van Staa TP, Cooper C. (2016). On epidemiology of fractures and variation with age and ethnicity. Bone. 93: 230-231 (full paper available here).
Klop C, Gibson-Smith D, Elders PJ, Welsing PM, Leufkens HG, Harvey NC, Bijlsma JW, van Staa TP, de Vries F. (2015). Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000-2010. Osteoporos Int. 26(7): 1919-28 (full paper available here).
Klop C, van Staa TP, Cooper C, Harvey NC, de Vries F. (2017). The epidemiology of mortality after fragility fracture in England and Wales: variation by age, sex, time, geographic location and ethnicity. Osteoporos Int. 28(1):161-168 (full paper available here).
Klop C, Welsing PM, Cooper C, Harvey NC, Elders PJ, Bijlsma JW, Leufkens HG, de Vries F. (2014). Mortality in British hip fracture patients, 2000-2010: a population-based retrospective cohort study. Bone. 66:171-7 (full paper available here).
Moon RJ, Harvey NC, Curtis EM, de Vries F, van Staa T, Cooper C. (2016). Ethnic and geographic variations in the epidemiology of childhood fractures in the United Kingdom. Bone. 85: 9-14 (full paper available here).
van der Velde RY, Wyers CE, Curtis EM, Geusens PP, van den Bergh JP, de Vries F, Cooper C, van Staa TP, Harvey NC. (2016). Secular trends in fracture incidence in the UK between 1990 and 2012. Osteoporos Int. 27(11):3197-3206 (full paper available here).
van der Velde RY, Wyers CE, Geusens PPMM, van den Bergh JPW, de Vries F, Cooper C, van de Staa TP, Harvey NC. (2018). Incidence of subsequent fractures in the UK between 1990 and 2012 among individuals 50 years or older. Osteoporos Int. 29(11):2469-2475 (full paper available here).
van der Velde RY, Wyers CE, Teesselink E, Geusens PPMM, van den Bergh JPW, de Vries F, Cooper C, Harvey NC, van Staa TP. (2017). Trends in oral anti-osteoporosis drug prescription in the United Kingdom between 1990 and 2012: variation by age, sex, geographic location and ethnicity. Bone. 94:50-55 (full paper available here).
Bullock L, Abdelmagid S, Fleming J, Leyland S, Clark EM, Gidlow C, Iglesias-Urrutia CP, O'Neill TW, Mallen C, Jinks C, Paskins Z. (2024). Variation in UK fracture liaison service consultation conduct and content before and during the COVID pandemic: results from the iFraP-D UK survey. Arch Osteoporos. 19, 5 (full paper available here).
Bullock L, Nicholls E, Cherrington A, Butler-Walley S, Clark EM, Fleming J, Leyland S, Bentley I, Thomas S, Iglesias-Urrutia CP, Webb D, Smith J, Bathers S, Lewis S, Clifford A, Siciliano M, Protheroe J, Ryan S, Lefroy J, Dale N, Hawarden A, Connacher S, Horne R, O'Neill TW, Mallen CD, Jinks C, Paskins Z. (2024). A person-centred consultation intervention to improve shared decision-making about, and uptake of, osteoporosis medicines (iFraP): a pragmatic, parallel-group, individual randomised controlled trial protocol. NIHR Open Res. Oct 2;4:14. (full paper available here).
Bullock L, Crawford-Manning F, Cottrell E, Fleming J, Leyland S, Edwards J, Clark EM, Thomas S, Chapman S, Gidlow C, Iglesias CP, Protheroe J, Horne R, O'Neill TW, Mallen C, Jinks C, Paskins Z. (2021). Developing a model Fracture Liaison Service consultation with patients, carers and clinicians: a Delphi survey to inform content of the iFraP complex consultation intervention Arch Osteoporos. 24;16(1):58 (full paper available here).
Crawford-Manning F, Greenall C, Hawarden A, Bullock L, Leyland S, Jinks C, Protheroe J, Paskins Z. (2021). Evaluation of quality and readability of online patient information on osteoporosis and osteoporosis drug treatment and recommendations for improvement. Osteoporos Int.32(8):1567-1584 (full paper available here).
Paskins Z, Bullock L, Crawford-Manning F, Cottrell E, Fleming J, Leyland S, Edwards JJ, Clark E, Thomas S, Chapman SR, Ryan S, Lefroy JE, Gidlow CJ, Iglesias C, Protheroe J, Horne R, O'Neill TW, Mallen C, Jinks C. (2021). Improving uptake of Fracture Prevention drug treatments: a protocol for Development of a consultation intervention (iFraP-D). BMJ Open. 11(8):e048811 (full paper available here).
Paskins Z, Bullock L, Manning F, Bishop S, Campbell P, Cottrell E, Partner GP, Jinks C, Narayanasamy M, Scott IC, Sahota O, Ryan S. (2022). Acceptability of, and preferences for, remote consulting during COVID-19 among older patients with two common long-term musculoskeletal conditions: findings from three qualitative studies and recommendations for practice. BMC Musculoskelet Disord. 23(1):312 (full paper available here).
Paskins Z, Crawford-Manning F, Bullock L, Jinks C. (2020). Identifying and managing osteoporosis before and after COVID-19: rise of the remote consultation? Osteoporos Int. 31(9): 1629-1632 (full paper available here).
Paskins Z, Torres Roldan VD, Hawarden AW, Bullock L, Meritxell Urtecho S, Torres GF, Morera L, Espinoza Suarez NR, Worrall A, Blackburn S, Chapman S, Jinks C, Brito JP. (2020). Quality and effectiveness of osteoporosis treatment decision aids: a systematic review and environmental scan. Osteoporos Int. 31(10): 837-1851 (full paper available here).
Palmer S, Barnett S, Cramp M, Berry A, Thomas A, Clark EM. (2018). Effects of postural taping on pain, function and quality of life following osteoporotic vertebral fractures-A feasibility trial. Musculoskeletal Care. 16(3):345-352 (full paper available here).
Abrahamsen B, Eiken P, Prieto-Alhambra D, Eastell R. (2016). Risk of hip, subtrochanteric, and femoral shaft fractures among mid and long term users of alendronate: nationwide cohort and nested case-control study. BMJ. 28;353:i3365(full paper available here).
Eiken PA, Prieto-Alhambra D, Eastell R, Abrahamsen B. (2017). Surgically treated osteonecrosis and osteomyelitis of the jaw and oral cavity in patients highly adherent to alendronate treatment: a nationwide user-only cohort study including over 60,000 alendronate users. Osteoporos Int. 28(10):2921-2928 (full paper available here).
Khalid S, Calderon-Larrañaga S, Hawley S, Ali MS, Judge A, Arden N, van Staa T, Cooper C, Javaid MK, Prieto-Alhambra D. (2018). Comparative anti-fracture effectiveness of different oral anti-osteoporosis therapies based on "real-world" data: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database. Clin Epidemiol. 10:1417-1431 (full paper available here).
Martín-Merino E, Petersen I, Hawley S, Álvarez-Gutierrez A, Khalid S, Llorente-Garcia A, Delmestri A, Javaid MK, Van Staa TP, Judge A, Cooper C, Prieto-Alhambra D. (2018). Risk of venous thromboembolism among users of different anti-osteoporosis drugs: a population-based cohort analysis including over 200,000 participants from Spain and the UK. Osteoporos Int. 29(2):467-478 (full paper available here).
Montgomery G, Tobias JH, Paskins Z, Khera TK, Huggins CJ, Allison SJ, Abasolo D, Clark EM, Ireland A. (2024). Daily Pain Severity but Not Vertebral Fractures Is Associated With Lower Physical Activity in Postmenopausal Women With Back Pain. J Aging Phys Act. Mar 23;32(3):428-437. (full paper available here).
Sheehan KJ, Bastas D, Guerra S, Creanor S, Hulme C, Lamb S, Martin FC, Sackley C, Smith T, Bell P, Hillsdon M, Pope S, Cook H, Godfrey E. (2024). Protocol for a feasibility randomised controlled trial of the 'Outdoor' mobility intervention for older adults after hip fracture. PLoS One. Aug 12;19(8):e0306871 (full paper available here).
Baji P, Patel R, Judge A, Johansen A, Griffin J, Chesser T, Griffin XL, Javaid MK, Barbosa EC, Ben-Shlomo Y, Marques EMR, Gregson CL; REDUCE Study Group. (2023). Organisational factors associated with hospital costs and patient mortality in the 365 days following hip fracture in England and Wales (REDUCE): a record-linkage cohort study. Lancet Healthy Longev. 4(8):e386-e398 (full paper available here).
Patel R, Drew S, Johansen A, Chesser T, Javaid MK, Griffin XL, Jones T, Griffin J, Bradshaw M, Whale K, Barbosa EC, Marques EMR, Ben-Shlomo Y, Gooberman-Hill R, Judge A, Gregson CL. (2021). REducing unwarranted variation in the Delivery of high qUality hip fraCture services in England and Wales (REDUCE): protocol for a mixed-methods study. BMJ Open. 11(5):e049763 (full paper available here).
Patel R, Judge A, Johansen A, Marques EMR, Griffin J, Bradshaw M, Drew S, Whale K, Chesser T, Griffin XL, Javaid MK, Ben-Shlomo Y, Gregson CL. (2022). Multiple hospital organisational factors are associated with adverse patient outcomes post-hip fracture in England and Wales: the REDUCE record-linkage cohort study. Age Ageing. 2;51(8):afac183 (full paper available here).
Aggarwal V, Maslen C, Abel RL, Bhattacharya P, Bromiley PA, Clark EM, Compston JE, Crabtree N, Gregory JS, Kariki EP, Harvey NC, Ward KA, Poole KES. On behalf of the Technology Working Group of the Osteoporosis and Bone Research Academy, Royal Osteoporosis Society. (2021). Opportunistic diagnosis of osteoporosis, fragile bone health and vertebral fractures from routine CT scans; a review of approved technology systems and pathways to Implementation. Ther Adv Musculoskel Dis. 13: 1–19. (full paper available here).
Gupta A, Maslen C, Vindlacheruvu M, Abel RL, Bhattacharya P, Bromiley PA, Clark EM, Compston JE, Crabtree N, Gregory JS, Kariki EP, Harvey NC, McCloskey E, Ward KA, Poole KES. On behalf of the Technology Working Group of the Osteoporosis and Bone Research Academy, Royal Osteoporosis Society. (2022). Digital health interventions for osteoporosis and post-fragility fracture Care. Ther Adv Musculoskel Dis. 14: 1–12. (full paper available here).
Paskins Z, Babatunde O, Sturrock A, Shean Toh L, Horne R, Maidment I, on behalf of the Effectiveness Working Group of the Royal Osteoporosis Society Osteoporosis and Bone Research Academy. (2022). Supporting patients to get the best from their osteoporosis treatment; what works for whom, why and in what circumstance: a rapid realist review. Osteoporos Int. 33(11)2245-2257. (full paper available here).
Frighi V, Smith M, Andrews TM, Clifton L, Collins GS, Fuller A, Roast J, Holt TA. (2022). Incidence of fractures in people with intellectual disabilities over the life course: a retrospective matched cohort study. eClinicalMedicine. 52:101656. (full paper available here).
Beaudart C, Sharma M, Clark P, Fujiwara S, Adachi JD, Messina OD, Morin SN, Kohlmeier LA, Sangan CB, Nogues X, Cruz-Priego GA, Cavallo A, Cooper F, Grier J, Leckie C, Montiel-Ojeda D, Papaioannou A, Raskin N, Yurquina L, Wall M, Bruyère O, Boonen A, Dennison E, Harvey NC, Kanis JA, Kaux JF, Lewiecki EM, Lopez-Borbon O, Paskins Z, Reginster JY, Silverman S, Hiligsmann M. (2023). Patients' preferences for fracture risk communication: the Risk Communication in Osteoporosis (RICO) study. Osteoporos Int. 2023 Epub ahead of print. (full paper available here).
Adams H, Salman L, Drinkwater KJ, Griffin J, Rowntree S, Howlett DC. (2025). Improved radiological diagnosis of osteoporotic vertebral fragility fractures following UK-wide interventions and re-audit-can this be maintained and translated into clinical practice? Osteoporos Int. Jun;36(6):1069-1076 (full paper available here).
Causes and mechanisms
Darling AL, Middleton BA, Gossiel F, Eastell R, Lanham-New SA, Skene DJ. (2025). Demonstration of an intrinsic circadian rhythm in bone resorption. Sci Rep. 15(1):32558 (full paper available here).
Orhadje E, Berg K, Whitehead K, Hauser B, Ralston SH. (2025). Height loss, back pain and severe pain are highly predictive of pregnancy associated osteoporosis. Osteoporos Int. Sep;36(9):1719-1724 (full paper available here)
Orhadje E, Makaram N, Berg K, Hauser B, Ralston SH. (2025). Clinical presentation, risk factors and management of pregnancy-associated osteoporosis: a systematic review and meta-analysis. Osteoporos Int. Jun;36(6):981-993 (full paper available here).
Orhadje E, Berg K, Hauser B, Ralston SH. (2023). Clinical features, incidence and treatment outcome in Pregnancy-Associated Osteoporosis: A single-centre experience over two decades. Calcif Tissue Int. 113(6):591-596 (full paper available here).
Hanusch BC, Tuck SP, McNally RJQ, Wu JJ, Prediger M, Walker J, Tang J, Piec I, Fraser WD, Datta HK, Francis RM. (2017). Does regional loss of bone density explain low trauma distal forearm fractures in men (the Mr F study)? Osteoporos Int. 28(10):2877-2886 (full paper available here).
Hauser B, Riches PL, Gilchrist T, Visconti M R, Wilson JF, Ralston SH. (2015). Autoantibodies to osteoprotegerin are associated with increased bone resorption in rheumatoid arthritis. Ann Rheum Dis. 74(8):1631-2 (full paper available here).
Hauser B, Riches PL, Wilson JF, Horne AM, Ralston SH. (2014). Prevalence and clinical prediction of osteoporosis in a contemporary cohort of patients with rheumatoid arthritis. Rheumatology. (134):1037-1044 (full paper available here).
Real A, Gilbert N, Hauser B, Kennedy N, Shand A, Gillett H, Gillett P, Goddard C, Cebolla Á, Sousa C, Fraser WD, Satsangi J, Ralston SH, Riches PL. (2015). Characterisation of Osteoprotegerin Autoantibodies in Coeliac Disease. Calcif Tissue Int. 97(2):125-33 (full paper available here).
Ma S, Goh EL, Tay T, Wiles CC, Boughton O, Churchwell JH, Wu Y, Karunaratne A, Bhattacharya R, Terrill N, Cobb JP, Hansen U, Abel RL. (2020). Nanoscale mechanisms in age-related hip-fractures. Sci Rep. 10(1):14208 (full paper available here).
Evans AL, Paggiosi MA, Eastell R, Walsh JS. (2015). Bone density, microstructure and strength in obese and normal weight men and women in younger and older adulthood. J Bone Miner Res. 30(5):920-8 (full paper available here).
Vilaca T, Evans A, Gossiel F, Paggiosi M, Eastell R, Walsh JS. (2022). Fat, adipokines, bone structure and bone regulatory factors associations in obesity. Eur J Endocrinol. 2022 Oct 26;187(6):743-750 (full paper available here).
McMichan L, Dick M, Skelton DA, Chastin SFM, Owen N, Dunstan DW, Fraser WD, Tang JCY, Greig CA, Agyapong-Badu S, Mavroeidi A. (2021). Sedentary behaviour and bone health in older adults: a systematic review. Osteoporos Int. 32(8):1487-1497 (full paper available here).
Hampson G, Edwards S, Sankaralingam A, Harrington DJ, Voong K, Fogelman I, Frost ML. (2015). Circulating concentrations of vitamin E isomers: Association with bone turnover and arterial stiffness in post-menopausal women. 81: 407-412 (full paper available here).
Hampson G, Edwards S, Conroy S, Blake GM, Fogelman I, Frost ML. (2013). The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women. Bone. 56(1):42-7 (full paper available here).
Ishtiaq S, Edwards S, Sankaralingam A, Evans BAJ, Elford C, Frost ML, Fogelman I, Hampson G. (2015). The effect of nitrogen containing bisphosphonates, zoledronate and alendronate, on the production of pro-angiogenic factors by osteoblastic cells. Cytokine. 71 (2): 154-160. (full paper available here).
Tobias JH, Duncan EL, Kague E, Hammond CL, Gregson CL, Bassett D, Williams GR, Min JL, Gaunt TR, Karasik D, Ohlsson C, Rivadeneira F, Edwards JR, Hannan FM, Kemp JP, Gilbert SJ, Alonso N, Hassan N, Compston JE, Ralston SH. Opportunities and challenges in functional genomics research in osteoporosis: report from a workshop Held by the Causes Working Group of the Osteoporosis and Bone Research Academyof the Royal Osteoporosis Society on October 5th 2020. (2021). Front Endocrinol (Lausanne). Feb 15;11:630875. (full paper available here).
Cronin O, Lanham-New S, Thompson B, Thompson F, Corfe BM, Gregson C, Darling A, Ahmadi K, Gibson PS, Gibson G, Tobias JH, Ward K, Traka M, Rossi M, Williams C, Harvey N, Cooper C, Whelan K, Uitterlinden AG, O’Toole PW, Ohlsson C, Compston JE, Ralston SH. Role of the intestinal microbiome in regulating bone metabolism and susceptibility to osteoporosis: Report from a workshop held by the Causes Working Group of the Osteoporosis and Bone Research Academy of the Royal Osteoporosis Society. (2022). Calcified Tissue International. 110:273–284. (full paper available here).
Prevention
Moon RJ, Harvey NC, Cooper C, D'Angelo S, Crozier SR, Inskip HM, Schoenmakers I, Prentice A, Arden NK, Bishop NJ, Carr A, Dennison EM, Eastell R, Fraser R, Gandhi SV, Godfrey KM, Kennedy S, Mughal MZ, Papageorghiou AT, Reid DM, Robinson SM, Javaid MK. (2016). Determinants of the Maternal 25-Hydroxyvitamin D Response to Vitamin D Supplementation During Pregnancy. The Journal of Clinical Endocrinology and Metabolism. 101: 12, 5012-5020 (full paper available here).
Walsh JS, Evans AL, Bowles S, Naylor KE, Jones KS, Schoenmakers I, Jacques RM, Eastell R. (2016). Free 25-hydroxyvitamin D is low in obesity, but there are no adverse associations with bone health. The American Journal of Clinical Nutrition. 103: 6, 1465-71(full paper available here).
Darling AL, Hart KH, Gossiel F, Robertson F, Hunt J, Hill TR, Johnsen S, Berry JL, Eastell R, Vieth R, Lanham-New SA. (2017). Higher bone resorption excretion in South Asian women vs. White Caucasians and increased bone loss with higher seasonal cycling of vitamin D: Results from the D-FINES cohort study. Bone. 98: 47-53 (full paper available here).
Antoniak AE and Greig CA. (2017). The effect of combined resistance exercise training and vitamin D3 supplementation on musculoskeletal health and function in older adults: a systematic review and meta-analysis. BMJ Open. 20;7(7): e014619 (full paper available here).
Welford AE, Lanham-New S, Lord J, Doyle A, Robinson J, Nightingale P, Gittoes N, Greig CA. (2020). Influence of combined vitamin D3 supplementation and resistance exercise training on musculoskeletal health in older men and women (EXVITD): protocol for a randomised controlled trial. BMJ Open. 10(3): e033824 (full paper available here).
Welford AE, Darling AL, Allison SJ, Lanham-New SA, Greig CA. (2022). Lack of significant seasonal association between serum 25(OH)D concentration, muscle mass and strength in postmenopausal women from the D-FINES longitudinal study. J Nutr Sci. 11: e107 (full paper available here).
Clarke M, Ward M, Dickey W, Hoey L, Molloy AM, Waldron L, Varghese A, McCann A, Blayney JK, McNulty H. (2015). B-vitamin status in relation to bone mineral density in treated celiac disease patients. Scand J Gastroenterol. 50(8):975-84 (full paper available here).
Clarke M, Ward M, Strain JJ, Hoey L, Dickey W, McNulty H. (2014). B-vitamins and bone in health and disease: the current evidence. Proc Nutr Soc. 73(2):330-9 (full paper available here).
Ward KA, Prentice A, Kuh DL, Adams JE, Ambrosini GL. (2016). Life Course Dietary Patterns and Bone Health in Later Life in a British Birth Cohort Study. J Bone Miner Res. 31(6):1167-76 (full paper available here).
Moore AE, Kim EJ, Dulnoan D, Dolan AL, Voong K, Ahmad I, Gorska R, Harrington DJ, Hampson G. (2020). Serum vitamin K1 (phylloquinone) is associated with fracture risk and hip strength in post-menopausal osteoporosis: A cross-sectional study. Bone. 141:115630 (full paper available here).
Macdonald HM, Wood AD, Aucott LS, Black AJ, Fraser WD, Mavroeidi A, Reid DM, Secombes KR, Simpson WG, Thies F. (2013). Hip bone loss is attenuated with 1000 IU but not 400 IU daily vitamin D3: a 1-year double-blind RCT in postmenopausal women. J Bone Miner Res. 28(10):2202-13 (full paper available here).
Duckham RL, Masud T, Taylor R, Kendrick D, Carpenter H, Iliffe S, Morris R, Gage H, Skelton DA, Dinan-Young S, Brooke-Wavell K. (2015). Randomised controlled trial of the effectiveness of community group and home-based falls prevention exercise programmes on bone health in older people: the ProAct65+ bone study. Age Ageing. 44(4):573-9 (full paper available here).
Research priorities
Paskins Z, Jinks C, Mahmood W, Jayakumar P, Sangan CB, Belcher J, Gwilym S. (2017). Public priorities for osteoporosis and fracture research: results from a general population survey. Arch Osteoporos. 12(1):45 (full paper available here).
Paskins Z, Moult A, Corp N, Bastounis A, Davis S, Narayanasamy MJ, Griffin J, Gittoes N, Leonardi-Bee J, Langley T, Bishop S, Sahota O. (2023). Research priorities regarding the use of bisphosphonates for osteoporosis: a UK priority setting exercise. Osteoporos Int. 34(10):1711-1718 (full paper available here).
Harvey, N.C., Poole, K.E., Ralston, S.H, McCloskey E.V, Sangan C.B, Wiggins L, Jones C, Gittoes N, Compston J and ROS Osteoporosis and Bone Research Academy (2022). Towards a cure for osteoporosis: the UK Royal Osteoporosis Society (ROS) Osteoporosis Research Roadmap. Arch Osteoporos.17 (1): 12. (full paper available here).
